Table 7 |
||
|
Difference between treatment groups in the magnitude of change from baseline to follow up in the service outcomes (ANOVA). |
||
|
Mean % |
||
|
|
||
|
Service delivery outcome indicator 15 intervention and 15 control districts |
Treatment group |
Magnitude of change |
|
|
||
|
9. DPT-3 coverage |
Intervention |
11.7% |
|
Control |
3.6% |
|
|
ANOVA |
P = 0.075 |
|
|
10. Polio-3 coverage |
Intervention |
26.5% |
|
Control |
17.1% |
|
|
ANOVA |
P = 0.159 |
|
|
11. HepB-3 coverage |
Intervention |
12.5% |
|
Control |
15.3% |
|
|
ANOVA |
P = 0.586 |
|
|
12. Contraindications rate (mean for monthly contraindication rates to account for seasonal variation in contraindications) |
Intervention |
-1.9% |
|
Control |
-0.5% |
|
|
ANOVA |
P = 0.192 |
|
|
13. Refusal rate (mean for monthly refusal rates to account for seasonal variation in contraindications) |
Intervention |
-1.5% |
|
Control |
-1.5% |
|
|
ANOVA |
P = 1.000 |
|
|
14. Vaccine wastage DPT (calculated as number of vaccinated children per 100 dose) |
Intervention |
4.9 |
|
Control |
-1.9 |
|
|
ANOVA |
P = 0.021 |
|
|
15. Vaccine wastage OPV (calculated as number of vaccinated children per 100 doses) |
Intervention |
0.6 |
|
Control |
-0.1 |
|
|
ANOVA |
P = 0.085 |
|
|
16. Vaccine wastage HEP B (calculated as number of vaccinated children per 100 doses) |
Intervention |
6.8 |
|
Control |
1.9 |
|
|
ANOVA |
P = 0.178 |
|
|
|
||
|
Djibuti et al. BMC International Health and Human Rights 2009 9(Suppl 1):S11 doi:10.1186/1472-698X-9-S1-S11 |
||
